• Non ci sono risultati.

Da Negro R. W.Balbi B.SPANEVELLO, ANTONIOmostra contributor esterni nascondi contributor esterni 

N/A
N/A
Protected

Academic year: 2021

Condividi "Da Negro R. W.Balbi B.SPANEVELLO, ANTONIOmostra contributor esterni nascondi contributor esterni "

Copied!
1
0
0

Testo completo

(1)

Monaldi Arch Chest Dis

2009; 71: 3, 92

EDITORIAL

Monaldi Archives for Chest Disease enters Clinical Pharmacology officially

R.W. Dal Negro 1 , B. Balbi 2 , A. Spanevello 3

The history of a scientific journal is a matter of great interest indeed, particularly when it provides enough detail on the most relevant changes have occurred during its lifetime. Just as in the case of Monaldi Archives for Chest Disease, first pub- lished on 1 January, 1946 under the title of “Archiv- io di Tisiologia” (Archive for Thysiology) by Vin- cenzo Monaldi, recognised worldwide as one of the most distinguished phthisiologists, , thus clearly re- flecting the original aim of the journal.

During the subsequent decades, the journal progressively broadened its scientific horizon and opened itself to contributions on non-tuberculous pathologies. Just to pinpoint this philosophy, the name of the journal was changed into “Archivio di Tisiologia e Malattie dell’Apparato Respiratorio”.

(Archive for Phthisiology and Diseases of the Res- piratory System).

The journal’s evolution was accelerated further by its two succeeding editors; Antonio Blasi who opened the doors to international contributors and updated the journal’s name to “Archivio Monaldi per la Tisiologia e le Malattie Respiratorie”

(Monaldi Archive for Phthisiology and Respirato- ry Disease), and by Ernesto Catena who further fa- cilitated contributions from different pneumologi- cal fields and changed the journal’s name to its present name: “Archivio Monaldi per le Malattie del Torace” (Monaldi Archives for Chest Disease).

A clear international vision for the journal was planned and achieved with the support of the Clin- ica del Lavoro Foundation, Institute of Care and Research, Pavia, Italy, and the English language became the official language for all scientists and researchers who contribute to the journal. At the beginning of the nineties, Monaldi Archives for Chest Disease entered the number of pneumologi- cal journals of international reputation.

During this period (1993), the Fondazione Salvatore Maugeri took over the journal and re- vamped its editorial mission according to the tendency of the Scientific Institute which is mainly oriented to the rehabilitation of respirato- ry, cardiovascular and neurological disabling diseases [1].

Therefore the evolutional journey of the jour-

nal started again, and new fields of scientific inter- est were added.

The reputation and the quality of the journal has further improved in recent years as well as its diffusion, and Cardiologic and Pulmonary series were issued separately since 2002.

More recently (2004), the Editorial Board of the Pulmonary series was renewed. The new co- Editors (Antonio Spanevello and Bruno Balbi), to- gether with the Deputy Editors (Mirco Lusuardi and Maurizio Luisetti), and the Executive Editors (Giuseppe Brunetti and Luca Bianchi) represent an efficient “under-fifties” staff of distinguished spe- cialists who all operate with the aim of further up- dating the journal’s perspectives [2].

The evolutional journey of Monaldi Archives for Chest Disease is however still not complete.

Clinical Pharmacology now represents the very new and challenging field which the Board decided to enter and operate actively. It represents a quite different topic from all previous ones in the journal’s tradition (such as, respiratory medicine;

pulmonary rehabilitation; health status evaluation;

educational activities, case reports, etc.).

This new editorial trend was decided with the aim of covering a relevant proportion of pul- monary science (both applicative and speculative) which is of ever increasing interest and still not of- ficially faced by the journal so far. The first Author of the present Editorial (Roberto W. Dal Negro) was appointed the Associate Editor for Clinical Pharmacology, and beginning with the present is- sue is already actively working towards achieving the journal’s further growth.

The intrinsic vitality of Monaldi Archives for Chest Disease is clearly mirrored by the capability of contin- uously adjusting its own philosophy and being able to promptly meet the scientific needs of all its readers.

Once again the future stems from our past.

References

1. Catena E, Grassi C. Our new Journal. Why? Monaldi Arch Chest Dis 1993; 48: 3.

2. Spanevello A, Balbi B. A new Editorial Board of Monaldi Archives for Chiest Disease. Monaldi Arch Chest Dis 2004; 61: 2-3.

Monaldi Arch Chest Dis 2009; 71: 3, 92.

1

Divisione di Pneumologia, Ospedale Orlandi, Bussolengo (Verona),

2

Divisione di Pneumologia Riabilitativa, Fondazione Salvatore Maugeri, I.R.C.C.S., Veruno (Novara),

3

Divisione di Pneumologia Riabilitativa, Fondazione Salvatore Maugeri, I.R.C.C.S., and Dipartimento di Medicina Clinica, Malattie dell'Apparato Respiratorio, Università degli Studi dell'Insubria, Tradate (Varese), Italy.

Correspondence: Dr. Roberto Dal Negro, Divisione di Pneumologia, Ospedale Orlandi, V. Ospedale 2, 37012 Bussolengo

(Verona), Italy; e-mail: rdalnegro@ulss22.ven.it

Riferimenti

Documenti correlati

We sample 共from the united atom to 10 000 bohr 兲 the PECs particularly in prox- imity of energy minima and avoided state crossing and at other selected internuclear separations

Motivation for this work comes not only from obtaining potential energy curves for the high excited states of H 2 but also from characterizing the electronic density evolution from

We aim (a) at the evaluation of the PECs starting at very short and unexplored internuclear distances (0.01 bohrs) and ending at full dissociation, (b) at the systematic prediction

Moreover, as an important result of ours, by modeling the environment by a chaotic quantum system, we determine a critical border in the coupling strength below which energy

The excessive airway nar- rowing observed in asthma may be related to the altered viscoelastic properties of lung parenchyma and airway wall, determining a decrease in the

Figure 2, instead, shows the convergence properties of the local energy expectation value computed as a function of time step obtained using importance sampled DMC simula- tions on

reported that the response in term of lung function to a two-week course of oral prednisolone increased as the baseline sputum eosinophilia count increased, and was associated with

Given the ease with which the appropriate deterministic benchmarks can be generated, and the fact that the convergence of parallel tempering on these systems has been measured